Exact Mass: 602.1447
Exact Mass Matches: 602.1447
Found 81 metabolites which its exact mass value is equals to given mass value 602.1447,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Amaroswerin
[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate
Amaroswerin is a member of biphenyls. Amaroswerin is a natural product found in Swertia japonica, Gentianella nitida, and other organisms with data available. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1]. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1].
Eriodictyol 7-(6-galloylglucoside)
(6-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3,4,5-trihydroxybenzoic acid
Eriodictyol 7-(6-galloylglucoside) is found in fruits. Eriodictyol 7-(6-galloylglucoside) is a constituent of the leaves and branches of Phyllanthus emblica (emblic). Constituent of the leaves and branches of Phyllanthus emblica (emblic). Eriodictyol 7-(6-galloylglucoside) is found in fruits.
QUINOLONE DERIVATIVE
7-{4-[2-(4-chlorophenyl)-2-({[hydroxy(pyridin-4-yl)methylidene]amino}imino)ethyl]piperazin-1-yl}-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
(2S)-5,7,3,4-Tetrahydroxyflavanone 7-(6-galloylglucoside)
(2S)-5,7,3,4-Tetrahydroxyflavanone 7-(6-galloylglucoside)
(-)-epicatechin 3-O-beta-D-(3-O-vanillil)allopyranoside
(-)-epicatechin 3-O-beta-D-(3-O-vanillil)allopyranoside
lissoclibadin 2
lissoclibadin 2
An organosulfur heterocyclic compound isolated from the ascidian Lissoclinum badium. It has been shown to exhibit cytotoxicity against human cancer cell lines.
3-hydroxy-4-O-beta-D-(6-O-vanilloylglucopyranosyl)benzyl vanilloate|litseaefoloside D
3-hydroxy-4-O-beta-D-(6-O-vanilloylglucopyranosyl)benzyl vanilloate|litseaefoloside D
(-)-epicatechin 3-O-beta-D-(2-O-vanillyl)allopyranoside
(-)-epicatechin 3-O-beta-D-(2-O-vanillyl)allopyranoside
(S)-5,7,3,5-tetrahydroxyflavanone-7-O-(6-galloyl)-beta-D-glucopyranose
(S)-5,7,3,5-tetrahydroxyflavanone-7-O-(6-galloyl)-beta-D-glucopyranose
1,2-dicaffeoyl-6-tuliposide A|1,2-O-dicaffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose
1,2-dicaffeoyl-6-tuliposide A|1,2-O-dicaffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose
1,4-dicaffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-caffeoyloxy-2-methylenebutyroyl)-beta-D-glucopyranose
1,4-dicaffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-caffeoyloxy-2-methylenebutyroyl)-beta-D-glucopyranose
1-methoxyoxalyl-3,5-dicaffeoylquinic acid|1-MO-3,5-DCQA|1-O-methoxyoxaloyl-3,5-di-O-caffeoylquinic acid
1-methoxyoxalyl-3,5-dicaffeoylquinic acid|1-MO-3,5-DCQA|1-O-methoxyoxaloyl-3,5-di-O-caffeoylquinic acid
[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate
NCGC00385446-01![(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate
Eriodictyol 7-(6-galloylglucoside)
(6-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3,4,5-trihydroxybenzoate
2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranosyl bromide
2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranosyl bromide
4-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-1-thiophen-2-ylpyrrolo[3,4-c]pyrrole-3,6-dione
4-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-1-thiophen-2-ylpyrrolo[3,4-c]pyrrole-3,6-dione
2,4-Hexadiyne-1,6-diol Bis(azobenzene-4-sulfonate)
2,4-Hexadiyne-1,6-diol Bis(azobenzene-4-sulfonate)
2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl bromide
2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl bromide
AVE 0991 sodium salt
AVE 0991 sodium salt
AVE 0991 sodium salt is a nonpeptide and orally active Ang-(1-7) receptor Mas agonist. AVE 0991 competes for high-affinity binding of [125I]-Ang-(1-7) to bovine aortic endothelial cell membranes with IC50 of 21 nM[1].
{4-[(2S,4E)-2-(1,3-Benzothiazol-2-YL)-2-(1H-1,2,3-benzotriazol-1-YL)-5-phenylpent-4-enyl]phenyl}(difluoro)methylphosphonic acid
{4-[(2S,4E)-2-(1,3-Benzothiazol-2-YL)-2-(1H-1,2,3-benzotriazol-1-YL)-5-phenylpent-4-enyl]phenyl}(difluoro)methylphosphonic acid
(2S)-eriodictyol 7-O-(6-O-galloyl)-beta-D-glucopyranoside
(2S)-eriodictyol 7-O-(6-O-galloyl)-beta-D-glucopyranoside
A monosaccharide derivative that is eriodictyol attached to a (6-O-galloyl)-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage.
7-[4-[(2E)-2-(4-chlorophenyl)-2-(pyridine-4-carbonylhydrazinylidene)ethyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
7-[4-[(2E)-2-(4-chlorophenyl)-2-(pyridine-4-carbonylhydrazinylidene)ethyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-(2s,3r,4r,5s,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl 6-(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1,6-dicarboxylate
1-(2s,3r,4r,5s,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl 6-(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1,6-dicarboxylate
(13r,23r)-13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
(13r,23r)-13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
4-[(2-carboxyacetyl)oxy]-3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid
4-[(2-carboxyacetyl)oxy]-3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid
6'-o-p-hydroxybenzoylcatalposide
NA
{"Ingredient_id": "HBIN012712","Ingredient_name": "6'-o-p-hydroxybenzoylcatalposide","Alias": "NA","Ingredient_formula": "C29H30O14","Ingredient_Smile": "C1=COC(C2C1C(C3C2(O3)CO)OC(=O)C4=CC=C(C=C4)O)OC5C(C(C(C(O5)COC(=O)C6=CC=C(C=C6)O)O)O)O","Ingredient_weight": "602.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9820","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706008","DrugBank_id": "NA"}
(6r,7r,8r)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone
(6r,7r,8r)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone
2-({4-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl}oxy)butane-1,2,4-tricarboxylic acid
2-({4-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl}oxy)butane-1,2,4-tricarboxylic acid
(1s,3r,4s,5r)-4-[(2-carboxyacetyl)oxy]-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid
(1s,3r,4s,5r)-4-[(2-carboxyacetyl)oxy]-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylic acid
2-(hydroxymethyl)-10-({3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl}oxy)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate
2-(hydroxymethyl)-10-({3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl}oxy)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate
(6r,7s,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone
(6r,7s,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone
(6s,7s,8s)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone
(6s,7s,8s)-4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone
13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate
2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate
(1s,3r,4s,5r)-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid
(1s,3r,4s,5r)-3,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid
(6'r,7'r,8'r)-2,4',6',7',8,8'-hexahydroxy-2',6-dimethoxy-3,7'-dimethyl-6',8'-dihydro-5'h-[1,1'-bianthracene]-9,9',10,10'-tetrone
(6'r,7'r,8'r)-2,4',6',7',8,8'-hexahydroxy-2',6-dimethoxy-3,7'-dimethyl-6',8'-dihydro-5'h-[1,1'-bianthracene]-9,9',10,10'-tetrone
4-[(2s,5r)-9'-[(3,3-dimethyloxiran-2-yl)methoxy]-4'-methoxy-4,4-dimethylspiro[1,3-dioxolane-2,7'-furo[3,2-g]chromen]-5-ylmethoxy]furo[3,2-g]chromen-7-one
4-[(2s,5r)-9'-[(3,3-dimethyloxiran-2-yl)methoxy]-4'-methoxy-4,4-dimethylspiro[1,3-dioxolane-2,7'-furo[3,2-g]chromen]-5-ylmethoxy]furo[3,2-g]chromen-7-one
1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone
1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone
(13s,23r)-13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
(13s,23r)-13,19,23-trihydroxy-29-(hydroxymethyl)-5,7-dimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
8-{9,10-dihydroxy-5,7-dimethoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-9,10-dihydroxy-5,7-dimethoxy-3-methylbenzo[g]isochromen-1-one
8-{9,10-dihydroxy-5,7-dimethoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-9,10-dihydroxy-5,7-dimethoxy-3-methylbenzo[g]isochromen-1-one
[(2r,3s,4s,5r,6s)-6-{[(2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
[(2r,3s,4s,5r,6s)-6-{[(2s)-2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(2s,3r)-1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate
(2s,3r)-1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate
4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone
4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone
4,6-bis[2-(dimethylamino)ethyl]-1,2,8,9-tetramethoxy-3,7-bis(methylsulfanyl)thianthrene-5,10-diium-5,10-bis(olate)
4,6-bis[2-(dimethylamino)ethyl]-1,2,8,9-tetramethoxy-3,7-bis(methylsulfanyl)thianthrene-5,10-diium-5,10-bis(olate)
1-[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl] 6-(3,4,5-trihydroxy-6-methyloxan-2-yl) phenazine-1,6-dicarboxylate
1-[4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl] 6-(3,4,5-trihydroxy-6-methyloxan-2-yl) phenazine-1,6-dicarboxylate
(2-{15-[2-(dimethylamino)ethyl]-6,7,12,13-tetramethoxy-5,14-bis(methylsulfanyl)-2,9,10-trithiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-4-yl}ethyl)dimethylamine
(2-{15-[2-(dimethylamino)ethyl]-6,7,12,13-tetramethoxy-5,14-bis(methylsulfanyl)-2,9,10-trithiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-4-yl}ethyl)dimethylamine
(2s)-2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid
(2s)-2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid
1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate
1,3,4-tris(4-hydroxybenzoyloxy)butan-2-yl 4-hydroxybenzoate
13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
13,19,23-trihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(17),2(11),4,6,8,18,20(25),26,28-nonaene-3,10,15,21-tetrone
3-[(1s,3s,4r,5r)-3,4-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,5-dihydroxycyclohexanecarbonyloxy]-3-oxopropanoic acid
3-[(1s,3s,4r,5r)-3,4-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,5-dihydroxycyclohexanecarbonyloxy]-3-oxopropanoic acid
(5'r,6'r,7'r)-1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone
(5'r,6'r,7'r)-1',2,5',6',7',8-hexahydroxy-3',6-dimethoxy-3,6'-dimethyl-7',8'-dihydro-5'h-[1,2'-bianthracene]-9,9',10,10'-tetrone
2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid
2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid
3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid
3,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-4-hydroxy-1-[(2-methoxy-2-oxoacetyl)oxy]cyclohexane-1-carboxylic acid
(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate
(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate
(2s,3r,4s,5s,6r)-2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate
(2s,3r,4s,5s,6r)-2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate
(6r,7r,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone
(6r,7r,8s)-4,4',6,7,7',8-hexahydroxy-1,1'-dimethoxy-6',7-dimethyl-6,8-dihydro-5h-[2,2'-bianthracene]-9,9',10,10'-tetrone
4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone
4,4',6,6',7,8-hexahydroxy-2,2'-dimethoxy-7,7'-dimethyl-6,8-dihydro-5h-[1,1'-bianthracene]-9,9',10,10'-tetrone
